Sun Pharmaceutical Industries Ltd, India's top drugmaker by market value, reported a net loss of 12.76-billion rupees while its net sales rose 31% to 34.82-billion rupees for the June-quarter. For the loss, the company blamed paying Pfizer Inc. $2.15-billion along with Teva Pharmaceuticals Industries Ltd, for settling a patent suit related to marketing generic versions of its acid-reflux drug Protonix.